| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | ADVANCED SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Tumour Genetics and Biology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan
2 Inserm UMR S392, Faculté de Pharmacie, 74 route du Rhin, BP 60024, 67401 Illkirch Cedex, France
3 Division of Surgical Oncology, Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama 700-8558, Japan
4 Department of Biomedical Research & Development, Link Genomics, Tokyo 103-0023, Japan
Checkpoints, which monitor DNA damage and regulate cell cycle progression, ensure genomic integrity and prevent the propagation of transformed cells. DNA damage activates the p53-dependent checkpoint pathway that induces expression of p21Cip1/WAF1, resulting in cell cycle arrest at G1/S transition by inhibition of cdk activity and DNA replication. ICBP90 was identified as a nuclear protein that binds to the TopoII
gene promoter and is speculated to be involved in DNA replication. ICBP90 expression is cell cycle regulated in normal cells but stably high throughout cell cycle in various cancer cell lines. We here demonstrate that ICBP90 expression is down-regulated by the p53/p21Cip1/WAF1-dependent DNA damage checkpoint signals. The reduction of ICBP90 appeared to be caused by both transcriptional suppression and protein degradation. Adenoviral expression of p21Cip1/WAF1 directly led to ICBP90 reduction in p53–/– HCT116 cells without DNA damage. Furthermore, ICPB90 depletion by RNA interference significantly blocked G1/S transition after DNA damage in HeLa cells. The down-regulation of ICBP90 is an important mechanism for cell cycle arrest at G1/S transition, which is induced by the activation of a p53/p21Cip1/WAF1-dependent DNA-damage checkpoint. Deregulation of ICBP90 may impair the control of G1/S transition during checkpoint activation and lead to genomic instability.
* Correspondence: E-mail: hsaya{at}gpo.kumamoto-u.ac.jp
This article has been cited by other articles:
|
|
 |
|
  J. K. Kim, P.-O. Esteve, S. E. Jacobsen, and S. Pradhan UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells Nucleic Acids Res., February 1, 2009; 37(2): 493 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. R. Woo, O. Pontes, C. S. Pikaard, and E. J. Richards VIM1, a methylcytosine-binding protein required for centromeric heterochromatinization Genes & Dev., February 1, 2007; 21(3): 267 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Sadler, K. N. Krahn, N. A. Gaur, and C. Ukomadu Liver growth in the embryo and during liver regeneration in zebrafish requires the cell cycle regulator, uhrf1 PNAS, January 30, 2007; 104(5): 1570 - 1575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Dugas, Y. C. Tai, T. P. Speed, J. Ngai, and B. A. Barres Functional Genomic Analysis of Oligodendrocyte Differentiation J. Neurosci., October 25, 2006; 26(43): 10967 - 10983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Jenkins, V. Markovtsov, W. Lang, P. Sharma, D. Pearsall, J. Warner, C. Franci, B. Huang, J. Huang, G. C. Yam, et al. Critical Role of the Ubiquitin Ligase Activity of UHRF1, a Nuclear RING Finger Protein, in Tumor Cell Growth Mol. Biol. Cell, December 1, 2005; 16(12): 5621 - 5629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Arima, M. Nitta, S. Kuninaka, D. Zhang, T. Fujiwara, Y. Taya, M. Nakao, and H. Saya Transcriptional Blockade Induces p53-dependent Apoptosis Associated with Translocation of p53 to Mitochondria J. Biol. Chem., May 13, 2005; 280(19): 19166 - 19176. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | ADVANCED SEARCH | TABLE OF CONTENTS |
